The film industry often prides itself on being a mirror to society, but sometimes, that mirror reflects images that trigger a fierce backlash. Such is the case with Sunny Deol’s upcoming action-thriller, Suryaa: Ant Se Aarambh Tak. As the film inches toward its scheduled November 20 release, it finds itself caught in the crosshairs of the Indian Medical Association (IMA), leading to a high-stakes standoff between creative expression and professional representation.
The tension reached a boiling point this week when the Ministry of Information and Broadcasting (I&B) confirmed that the Central Board of Film Certification (CBFC) has yet to even receive the film for review. This revelation serves as a sobering reminder that the path from the editing suite to the cinema screen is rarely a straight line, especially when institutional interests feel their reputations are on the chopping block.
The Trigger: Why the IMA is Raising Alarms
The controversy stems from the teaser of Suryaa, which paints a bleak picture of the medical fraternity. According to the IMA’s formal complaint addressed to Union Minister Ashwini Vaishnaw, the promotional material for the film doesn’t just tell a story; it allegedly paints an entire profession with a broad, derogatory brush.
In a letter dated October 22, the medical body expressed “serious concern” regarding the film’s narrative trajectory. The IMA argues that the film’s portrayal of corruption within the healthcare sector is not merely a plot device, but a dangerous generalization that risks eroding the already fragile trust between patients and practitioners. In an era where the public is increasingly skeptical of institutional integrity, the IMA fears that a cinematic depiction of widespread systemic rot could fuel hostility toward honest, hardworking doctors who are already operating under immense pressure.
Normalizing the Unthinkable: The Violence Narrative
Perhaps the most alarming aspect for the medical community is the film’s depiction of physical aggression. The IMA’s letter specifically flags scenes where physical assaults on doctors and nursing staff appear to be framed through a “heroic” lens. For a profession that has witnessed a rise in workplace violence, the prospect of such actions being glorified on the silver screen is not just a creative critique—it’s a safety issue.
“Scenes depicting physical assaults on doctors, nursing staff, and hospital personnel, particularly when presented as heroic or justified acts, risk normalizing violence against those committed to saving lives,” the IMA wrote. The association emphasized that for those on the frontlines, these aren’t just fictional tropes; they are reflections of a reality that already places healthcare workers in harm’s way. By turning an act of violence into a cinematic “win” for the protagonist, the film is being accused of inadvertently inciting real-world hostility.
The Call for Censorship vs. Creative Liberty
The IMA is not calling for a total suppression of dissent or a refusal to show corruption. In fact, they explicitly clarified that they do not support misconduct or unethical practices. However, they are demanding accountability. They have urged the I&B Ministry to conduct an impartial review of the film’s content, essentially calling for the CBFC to step in as a moral arbiter.
The association has requested that the government consider “suitable corrective steps,” which, in the language of formal complaints, often hints at the possibility of a ban or at least mandatory edits to the most incendiary scenes. This places the Ministry and the CBFC in a precarious position. If they clamp down, they risk the ire of the creative community, who will scream “censorship.” If they remain silent, they face the growing, organized pressure of a massive professional association that represents the backbone of the country’s health infrastructure.
What ‘Suryaa’ Actually Promises
For the uninitiated, Suryaa: Ant Se Aarambh Tak is classic Sunny Deol fare. The teaser teases a narrative driven by personal vengeance—a man scarred by a tragic loss who unearths a sinister truth within the medical system. It is a story of a “lone wolf” taking on a “hidden” systemic evil. Historically, this is a genre that has performed exceptionally well in the Indian market; audiences love a hero who defies the status quo.
However, the film’s reliance on the “corrupt doctor” trope is a tired narrative device that the IMA clearly feels has outstayed its welcome. With a stellar ensemble cast—including Ravi Kishan, Pragya Jaiswal, and Jisshu Sengupta—the film certainly has the pedigree to make noise. The question now is whether that noise will be drowned out by the legal and professional pushback currently brewing.
The Clock is Ticking for the November 20 Deadline
With the release date of November 20 looming, time is running out. The fact that the film has not yet been submitted to the CBFC suggests that the producers may be facing last-minute hurdles or are simply navigating the typical bureaucratic maze. However, given the IMA’s high-profile intervention, the certification process will likely be under much higher scrutiny than usual.
As for Sunny Deol, he is no stranger to controversies, but this battle pits him against one of the most organized and vital sectors of society. Whether the film reaches the screen as-is, with redactions, or with a delay remains to be seen. What is clear, however, is that Suryaa has already sparked a critical conversation about the power of media to influence public perception—and the real-world consequences that follow when the line between cinematic entertainment and institutional defamation becomes blurred. For now, the audience waits, and the medical community watches, both with a vested interest in the final cut.
Disclaimer: This content is auto-generated for informational purposes only.
Source: Read Original News
